Why Financial Due Diligence Isn't Enough in Healthcare

Healthcare continues to attract strong investor interest.

Demographic change, increasing demand, clinical innovation and fragmented markets all create opportunities for growth. Many healthcare businesses also offer recurring revenue, defensible referral networks and the potential to expand into adjacent services.

However, healthcare is unlike almost any other industry.

A business can demonstrate strong historical financial performance while carrying strategic, operational, workforce or clinical risks that are difficult to identify through financial due diligence alone.

For investors, understanding these risks before a transaction is often the difference between acquiring a strong platform and inheriting a complex operational challenge.

Financial Performance Is Only Part of the Investment Story

Financial due diligence provides an essential view of historical earnings, working capital, cash conversion and the quality of reported performance.

It helps investors understand what the business has achieved.

It does not always explain whether that performance is sustainable, how the business creates value in practice or what will be required to deliver the investment thesis.

In healthcare, future performance is often shaped by factors that sit outside the financial statements.

These include:

• How patients enter the business.

• The strength and concentration of referral pathways.

• Dependence on individual clinicians, contracts or funders.

• Workforce capacity, productivity and succession risk.

• Clinical quality, governance and regulatory compliance.

• Utilisation of facilities, equipment and clinical capacity.

• The resilience of technology and operating systems.

• The ability to expand across services, locations or patient groups.

• The investment required to support future growth.

These factors can materially affect both risk and enterprise value.

Follow the Patient and the Revenue

One of the most important questions in healthcare due diligence is how patients enter and move through the business.

Revenue may appear diversified at a financial level while depending heavily on a small number of referrers, specialists, contracts or funding arrangements.

Investors should understand:

• Who controls or influences referrals.

• Whether referral relationships are institutional or personal.

• How easily patients can move to competing providers.

• Whether demand is constrained by market size, workforce or capacity.

• How conversion from referral to consultation, diagnosis or treatment occurs.

• Where patients leave the pathway before receiving a service.

This analysis helps distinguish sustainable demand from performance that may be concentrated, temporary or difficult to replicate.

Understand the Clinical and Workforce Model

Healthcare businesses are often highly dependent on scarce and specialised people.

A strong brand, attractive market and high-quality facilities will not create value if the organisation cannot recruit, retain and effectively deploy the clinicians required to deliver services.

Due diligence should therefore assess:

• Reliance on a small number of senior clinicians.

• Employment, contracting and incentive arrangements.

• Recruitment pipelines and time required to fill vacancies.

• Succession plans for founders and key specialists.

• Clinical productivity and utilisation.

• The balance between clinical and administrative work.

• Workforce models required to support growth.

• The strength of clinical leadership and governance.

This is particularly important in founder-led businesses, where commercial relationships, clinical reputation and decision-making authority may be closely linked to one or two individuals.

Test the Operating Model

Historical growth does not necessarily mean that a business is ready to scale.

Some healthcare providers grow through individual effort, informal relationships and manual processes. These approaches may be effective at a smaller scale but become fragile as the organisation expands.

Investors should test whether the operating model can support the next stage of growth.

Key questions include:

• Are responsibilities and decision rights clear?

• Are processes standardised where they need to be?

• Can performance be compared across sites, clinicians or service lines?

• Is capacity visible and actively managed?

• Are billing, scheduling and reporting processes reliable?

• Does management have the information required to make timely decisions?

• Can new sites or services be integrated without excessive complexity?

• Which functions will require additional investment after acquisition?

A scalable healthcare platform requires more than demand. It needs repeatable operating disciplines.

Assess Quality, Governance and Regulatory Risk

Clinical quality is not separate from commercial performance.

Poor governance, inconsistent quality systems or weak compliance can create significant financial, reputational and operational exposure.

A robust assessment should consider:

• Clinical governance structures.

• Credentialling and scope-of-practice controls.

• Incident reporting and escalation.

• Quality assurance and audit processes.

• Accreditation and regulatory obligations.

• Privacy, cybersecurity and patient information management.

• Health and safety systems.

• Complaints, claims and litigation history.

• The consistency of standards across locations.

The purpose is not simply to identify compliance gaps. It is to understand whether the organisation has the leadership, systems and culture required to maintain quality as it grows.

Determine Whether Technology Enables Growth

Technology is often treated as an IT workstream within due diligence.

In healthcare, it is part of the operating model.

Investors should understand whether existing systems support clinical delivery, billing, scheduling, reporting, compliance and patient engagement.

They should also identify where fragmented or ageing systems could create future cost.

Questions may include:

• Are clinical and administrative systems integrated?

• Is data accurate, accessible and trusted?

• Can management report performance by site, service and clinician?

• Are staff relying on manual workarounds or duplicate entry?

• Can systems support acquisitions and new locations?

• What cybersecurity and continuity risks exist?

• Which investments are essential, and which are optional?

A technology roadmap should be linked to the value creation plan rather than treated as a separate modernisation exercise.

Evaluate the Market and Funding Environment

Healthcare demand may be resilient, but revenue models can still be exposed to change.

A business may depend on public funding, private insurance, ACC, employer arrangements, direct patient payments or a combination of these.

Each has different risks and growth dynamics.

Commercial due diligence should assess:

• The underlying demand for the service.

• Demographic and epidemiological drivers.

• Current and emerging competitors.

• Funding and reimbursement trends.

• The relative bargaining power of funders and providers.

• Barriers to entry.

• Substitution by new technologies or models of care.

• Policy and regulatory developments.

• Opportunities in adjacent services or geographies.

The objective is not simply to confirm that the market is growing. It is to determine whether the target is positioned to capture that growth profitably.

Due Diligence Should Test the Value Creation Plan

The strongest due diligence processes do more than identify risk.

They test how value will be created after acquisition.

Potential opportunities may include:

• Increasing utilisation of existing clinical capacity.

• Strengthening referral pathways.

• Improving workforce deployment and productivity.

• Expanding into adjacent services.

• Entering underserved markets or locations.

• Standardising processes across sites.

• Improving scheduling, billing and revenue-cycle performance.

• Strengthening data and management reporting.

• Reducing unnecessary complexity.

• Integrating complementary acquisitions.

• Investing in technology that supports scale.

Each opportunity should be tested against market demand, workforce availability, capital requirements, management capability and implementation risk.

A value creation plan is only useful if the organisation can deliver it.

A Practical Healthcare Due Diligence Framework

Coriolis assesses healthcare businesses across seven connected dimensions:

1. Market

Is demand sustainable, and how attractive is the competitive and funding environment?

2. Patient and Referral Pathways

How do patients enter the business, and how secure are the relationships that drive activity?

3. Clinical and Workforce Model

Does the organisation have the people, leadership and clinical capacity required to maintain quality and support growth?

4. Operating Model

Can the business deliver services consistently, productively and at greater scale?

5. Governance and Quality

Are clinical governance, compliance and risk-management systems fit for the current business and its future ambitions?

6. Technology and Infrastructure

Will existing systems and assets support the investment thesis, or will significant additional investment be required?

7. Value Creation and Deliverability

Where can value be created, and does the organisation have the capability, resources and time to achieve it?

These dimensions should be considered together.

A weakness in one area can constrain performance across the entire business.

Sector Experience Changes the Questions

Healthcare is a complex sector where commercial success is closely linked to clinical delivery, workforce capability, funding arrangements, regulation and patient experience.

Understanding these relationships requires more than analysing reported performance.

It requires the ability to recognise how healthcare services operate in practice, where capacity is created or lost, how clinical and commercial incentives interact, and which improvement opportunities can genuinely be delivered.

That perspective helps investors distinguish between a compelling investment thesis and an attractive set of assumptions.

Successful Investments Require More Than Strong Financials

Financial due diligence remains a critical part of every healthcare transaction.

It explains how the business has performed and helps establish the quality of historical earnings.

However, it is only one part of the investment picture.

Investors also need to understand how patients enter the business, how clinicians and infrastructure create capacity, where operational dependencies sit and whether the proposed value creation plan can be delivered in practice.

The most successful healthcare investments are built on a clear understanding of the financial, strategic, operational and clinical story.

Not only what the business has achieved, but what it has the capability to become.

Coriolis Perspective

In healthcare, sustainable value is determined by more than market growth and historical earnings. Investors need to understand how patients enter the business, how clinicians and infrastructure create capacity, payer relations and how funding models may change, where operational dependencies sit and whether the value creation plan can be delivered in practice.